ELISA binding of MonoRabTM SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052) with recombinant SARS-CoV-2 Spike Protein S1 RBD(GenScript, Z03483) and SARS-CoV RBD .
MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052) blocks SARS-CoV-2 Omicron RBD binding with Human ACE2 recombinant protein by sVNT.
SARS-CoV-2 S-RBD Omicron/B.1.1.529 (GenScript, )
MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit dilution start from 10 µg/ml.
Pseudovirus Neutralization Test of SARS-CoV-2 pseudovirus–hACE2 interaction with MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052).
Control: HEK293/ACE2 cells were infected with SARS-CoV-2 pseudovirus
SARS-CoV-2 Pseudovirus Neutralization Assay kit_Luc reporter (GenScript, L02087A)
SARS-CoV-2 B.1.617.2 (Delta) Pseudovirus Neutralization Assay kit _Luc reporter (GenScript, L02087V)
SARS-CoV-2 B.1.1.529 (Omicron) Pseudovirus Neutralization Assay kit _Luc reporter (GenScript, L02087-027)
MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052) dilutions start from 40 µg/ml.
Dose-response curve of MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052) on SARS-CoV-2 Multiplex sVNT.
The final concentration of RBD recombinant proteins were 60 ng/mL. MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052) dilutions started from 10 µg/mL.
MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit (GenScript, A02052) can block the binding of SARS-CoV-2 omicron variant XBB sublineage and BQ.1.1 sublineage to Human ACE2.
MonoRab™ SARS-CoV-2 Neutralizing Antibody (BS-R2B17), mAb, Rabbit
|
A02052 |
|
|
|
|
|
¥2800 |
|
|
|
|
联系黄金城集团 |